Justine Whitmore, Head of Workforce Development and Wellbeing at George Eliot Hospital NHS Trust, has been awarded the prestigious Clinician of the Year (Nursing) Award at the NHS England Midlands Covid-19 Vaccination Awards for her success overseeing the roll out of the Covid-19 vaccination service at the Trust.
The project started its rapid development on Christmas Eve 2020 and just 11 days later, 4th January 2021, delivered its first lifesaving Oxford/Astra Zeneca vaccination.
Since then, the service has given over 30,000 vaccinations to hospital staff, healthcare workers, patients and the local community.
Due to its success the service was also chosen to expand to deliver specialist clinics for the region, including for people who have a learning disability, people with allergies and clinics for pregnant women. In June 2021, the service became a hospital hub plus site.
Justine, who was chosen from among almost 400 nominations from across the Midlands: “I’m so proud to receive this award. Ours is more than just a vaccination service, the team and I have worked hard to build relationships and break down barriers to ensure that everyone who would like to be vaccinated can be vaccinated.”
George Eliot Hospital’s Chief People Officer, Gertie Nic Philib, who nominated Justine for the award, said: “It is wonderful to see the well-earned recognition of the great work Justine has done for her outstanding work on vaccinations over this past year and a half.
“Justine’s work has been key to our providing and expanding our vaccination service and ensuring that the support we offer our staff, and the wider community, has been compassionate and in line with the Trust values.”
Justine added: “A reminder that we’re still open for business. We now offer all three types of Covid-19 vaccine (AstraZeneca, Pfizer and Moderna). If you need your booster, pop by and see us. There’s no need to book as we offer walk in appointment. If you have a query, come and have a conversation with us. It’s not too late to get vaccinated against Covid-19.”